» Articles » PMID: 28125680

Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ

Overview
Journal PLoS One
Date 2017 Jan 27
PMID 28125680
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoic acid (RA) plays key roles in cell differentiation and growth arrest through nuclear retinoic acid receptors (RARs), which are ligand-dependent transcription factors. While the main trigger of RAR activation is the binding of RA, phosphorylation of the receptors has also emerged as an important regulatory signal. Phosphorylation of the RARγ N-terminal domain (NTD) is known to play a functional role in neuronal differentiation. In this work, we investigated the phosphorylation of RARγ ligand binding domain (LBD), and present evidence that the phosphorylation status of the LBD affects the phosphorylation of the NTD region. We solved the X-ray structure of a phospho-mimetic mutant of the LBD (RARγ S371E), which we used in molecular dynamics simulations to characterize the consequences of the S371E mutation on the RARγ structural dynamics. Combined with simulations of the wild-type LBD, we show that the conformational equilibria of LBD salt bridges (notably R387-D340) are affected by the S371E mutation, which likely affects the recruitment of the kinase complex that phosphorylates the NTD. The molecular dynamics simulations also showed that a conservative mutation in this salt bridge (R387K) affects the dynamics of the LBD without inducing large conformational changes. Finally, cellular assays showed that the phosphorylation of the NTD of RARγ is differentially regulated by retinoic acid in RARγWT and in the S371N, S371E and R387K mutants. This multidisciplinary work highlights an allosteric coupling between phosphorylations of the LBD and the NTD of RARγ and supports the importance of structural dynamics involving electrostatic interactions in the regulation of RARs activity.

Citing Articles

Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity.

Carazo A, Macakova K, Matousova K, Krcmova L, Protti M, Mladenka P Nutrients. 2021; 13(5).

PMID: 34069881 PMC: 8157347. DOI: 10.3390/nu13051703.


A structural signature motif enlightens the origin and diversification of nuclear receptors.

Beinsteiner B, Markov G, Erb S, Chebaro Y, McEwen A, Cianferani S PLoS Genet. 2021; 17(4):e1009492.

PMID: 33882063 PMC: 8092661. DOI: 10.1371/journal.pgen.1009492.


Allostery in Its Many Disguises: From Theory to Applications.

Wodak S, Paci E, Dokholyan N, Berezovsky I, Horovitz A, Li J Structure. 2019; 27(4):566-578.

PMID: 30744993 PMC: 6688844. DOI: 10.1016/j.str.2019.01.003.

References
1.
Glass C, Rosenfeld M . The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000; 14(2):121-41. View

2.
Rostkowski M, Olsson M, Sondergaard C, Jensen J . Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct Biol. 2011; 11:6. PMC: 3038139. DOI: 10.1186/1472-6807-11-6. View

3.
Grosdidier S, Carbo L, Buzon V, Brooke G, Nguyen P, Baxter J . Allosteric conversation in the androgen receptor ligand-binding domain surfaces. Mol Endocrinol. 2012; 26(7):1078-90. PMC: 5416996. DOI: 10.1210/me.2011-1281. View

4.
Schuttelkopf A, van Aalten D . PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 8):1355-63. DOI: 10.1107/S0907444904011679. View

5.
Phillips J, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E . Scalable molecular dynamics with NAMD. J Comput Chem. 2005; 26(16):1781-802. PMC: 2486339. DOI: 10.1002/jcc.20289. View